2m 2m 2m 2m 2m 2m 2m
Bristol-MyersSqu (BMY)
NYSE
$55.78+$1.07 (+1.97%)
Price as of Jun 23, 2026 5:27 PM EDT- $111.7BMarket Cap
- 22.41%1-Year Change
- Drug Manufacturers - GeneralIndustry
Bristol-MyersSqu (BMY)
$55.78+$1.07 (+1.97%)
BMY | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $54.70 | ||
Change | +$0.70 (+1.30%) | ||
Open | $54.20 | ||
High | $54.73 | ||
Low | $53.99 | ||
Previous Close | $54.00 | ||
Volume | 16,238,855 | ||
30-Day Average Volume | 13,516,244 | ||
1-Week Change | -2.74% | ||
1-Month Change | -8.01% | ||
1-Year Change | 22.41% | ||
3-Year Change | -3.76% | ||
5-Year Change | 1.41% | ||
Fundamentals | |||
Shares Outstanding | 2.0B | ||
Total Assets | $86.5B | ||
Market Cap | $111.7B | ||
Enterprise Value | $146.6B | ||
Period: QTR TTM FY | |||
Revenue | $11.2B | ||
Net Income | $2.7B | ||
Free Cash Flow | $757.0M | ||
EBIT | $3.2B | ||
EBITDA | $3.8B | ||
Net Working Capital | $8.1B | ||
EPS | $1.31 | ||
Enterprise Value/EBITDA | 38 | ||
Enterprise Value/Revenue | 13 | ||
P/B | 6 | ||
P/E | 42 | ||
PEG | 0 | ||
Price/Free Cash Flow | 148 | ||
Price/Operating Cash Flow | 101 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 4.61% | ||
Trailing Annual Dividend Yield | 4.57% | ||
Ex-Dividend Date | 07/02/2026 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue
Annual Dividend Yield